The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
Primary Purpose
Diabetes Mellitus Type 2
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
injection-meal-interval
Sponsored by

About this trial
This is an interventional treatment trial for Diabetes Mellitus Type 2 focused on measuring injection to meal time, human insulin
Eligibility Criteria
Inclusion Criteria:
- Type 2 diabetes mellitus
- Aged 40 - 80 years
- Therapy with human insulin
Exclusion Criteria:
- Pregnancy
- Nutrition disorders
- Psychological disease
- Body Mass Index (BMI) less than 25 kg/m^2
- HbA1c greater than 9%
Sites / Locations
- Friedrich-Schiller-University, department of internal medicine III
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
A
B
Arm Description
with injection-meal-interval,cross over after 3 month, than without injection-meal-interval for 3 month
without injection-meal-interval,cross over after 3 month, than with injection-meal-interval for 3 month
Outcomes
Primary Outcome Measures
HbA1c
Secondary Outcome Measures
Hypoglycemia
Treatment satisfaction
Quality of Life
Full Information
NCT ID
NCT00529165
First Posted
September 13, 2007
Last Updated
January 12, 2009
Sponsor
University of Jena
1. Study Identification
Unique Protocol Identification Number
NCT00529165
Brief Title
The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
Study Type
Interventional
2. Study Status
Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
July 2007 (undefined)
Primary Completion Date
July 2008 (Actual)
Study Completion Date
January 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University of Jena
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to demonstrate, that there is no difference in metabolic control in patients with type 2 diabetes mellitus and therapy with human insulin with or without injection-meal-interval.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus Type 2
Keywords
injection to meal time, human insulin
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Description
with injection-meal-interval,cross over after 3 month, than without injection-meal-interval for 3 month
Arm Title
B
Arm Type
Experimental
Arm Description
without injection-meal-interval,cross over after 3 month, than with injection-meal-interval for 3 month
Intervention Type
Procedure
Intervention Name(s)
injection-meal-interval
Intervention Description
The patient injects human insulin (as Actrapid from NovoNordisc) as usual in their insulin routine. The injection is subcutaneous and the dosage is dependent on the blood glucose monitoring. Patients will inject insulin previous every meal, with the following differences:
Group A: with injection-meal-interval: 50 patients educated to inject the insulin with an injection-meal-interval of 15 minutes
Group B: without injection-meal-interval: 50 patients educated to inject the insulin without injection-meal-interval
Cross-over will occur to the other group after 12 weeks. The follow up is 28 weeks.
Primary Outcome Measure Information:
Title
HbA1c
Time Frame
Week 16 and 28
Secondary Outcome Measure Information:
Title
Hypoglycemia
Time Frame
Week 16 and 28
Title
Treatment satisfaction
Time Frame
week 16 and 28
Title
Quality of Life
Time Frame
week 16 and 28
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Type 2 diabetes mellitus
Aged 40 - 80 years
Therapy with human insulin
Exclusion Criteria:
Pregnancy
Nutrition disorders
Psychological disease
Body Mass Index (BMI) less than 25 kg/m^2
HbA1c greater than 9%
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ulrich A Mueller, Professor
Organizational Affiliation
University of Jena, department of internal medicine III
Official's Role
Principal Investigator
Facility Information:
Facility Name
Friedrich-Schiller-University, department of internal medicine III
City
Jena
ZIP/Postal Code
07740
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
23340895
Citation
Muller N, Frank T, Kloos C, Lehmann T, Wolf G, Muller UA. Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes and human insulin. Diabetes Care. 2013 Jul;36(7):1865-9. doi: 10.2337/dc12-1694. Epub 2013 Jan 22.
Results Reference
derived
PubMed Identifier
21219434
Citation
Muller N, Kloos C, Frank T, Ristow M, Wolf G, Muller UA. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes. Diabet Med. 2011 Feb;28(2):223-6. doi: 10.1111/j.1464-5491.2010.03172.x.
Results Reference
derived
Learn more about this trial
The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
We'll reach out to this number within 24 hrs